Canaccord Genuity initiated coverage on Histogen
$HSTO
Biotechnology: Pharmaceutical Preparations
Health Care
Canaccord Genuity initiated coverage of Histogen with a rating of Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/30/2021 | $2.40 | Buy | HC Wainwright & Co. |